Abstract
Neuromuscular blocking agents (NMBAs) are extensively used in patients who present with acute respiratory distress syndrome (ARDS). The role of NMBAs has been extensively discussed in the past, primarily due to their potential adverse effects and the absence of clear evidence regarding their influence on prognosis. However, recent data have demonstrated that NMBAs are associated with a reduction in mortality in the most severe patients. Currently, the role of paralytics in the care of ARDS patients is proven. The positive effects of paralytics are probably due to the facilitation of protective ventilation, the prevention of ventilator-induced lung injury and the limitation of derecruitment. However, the role of NMBAs should be limited to severe and most hypoxaemic forms of moderate ARDS. NMBAs probably have a crucial role to play in the acute phase of ARDS, i.e. during the climax of lung injury, especially in association with other therapies, such as prone positioning. The use of NMBAs should always be integrated into the overall management strategy for the mechanical ventilation of ARDS patients, and NMBAs should be discontinued as soon as the patient improves sufficiently to allow for partial spontaneous breathing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW, Tescher AN et al (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30:142–156
Szakmany T, Woodhouse T (2015) Use of cisatracurium in critical care: a review of the literature. Minerva Anestesiol 81:450–460
Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336
Arroliga A, Frutos-Vivar F, Hall J, Esteban A, Apezteguia C, Soto L et al (2005) Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest J 128:496–506
Guérin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T et al (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:2159–2168
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800
Vender JS, Szokol JW, Murphy GS, Nitsun M (2004) Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 32:S554–S561
Needham CJ, Brindley PG (2012) The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome. Can J Anesth Can Anesth 59:105–108
Stark AR, Bascom R, Frantz ID (1979) Muscle relaxation in mechanically ventilated infants. J Pediatr 94:439–443
Bishop MJ (1984) Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. J Am Soc Anesthesiol 60:369–371
Coggeshall JW, Marini JJ, Newman JH (1985) Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med 145:1718–1720
Lagneau F, D’honneur G, Plaud B, Mantz J, Gillart T, Duvaldestin P et al (2002) A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med 28:1735–1741
Gainnier M, Roch A, Forel J-M, Thirion X, Arnal J-M, Donati S et al (2004) Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome*: Crit. Care Med 32:113–119
Forel J-M, Roch A, Marin V, Michelet P, Demory D, Blache J-L et al (2006) Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34:2749–2757
Papazian L, Forel J-M, Gacouin A, Penot-Ragon C, Perrin G, Loundou A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363(12):1107–1116
Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J et al (2013) Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 17:R43
Neto AS, Pereira VGM, Espósito DC, Damasceno MCT, Schultz MJ (2012) Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care 2:33
Rehder K, Sessler AD, Rodarte JR (1977) Regional intrapulmonary gas distribution in awake and anesthetized-paralyzed man. J Appl Physiol 42:391–402
Tokics L, Hedenstierna G, Svensson L, Brismar B, Cederlund T, Lundquist H et al (1996) V˙/Q˙ distribution and correlation to atelectasis in anesthetized paralyzed humans. J Appl Physiol 81:1822–1833
Brismar B, Hedenstierna G, Lundquist H, Strandberg Å, Svensson L, Tokics L (1985) Pulmonary densities during Anesthesia with muscular relaxation—a proposal of atelectasis. J Am Soc Anesthesiol 62:422–428
Hedenstierna G, Strandberg Å, Brismar B, Lundquist H, Svensson L, Tokics L (1985) Functional Residual Capacity, Thoracoabdominal Dimensions, and Central Blood Volume during General Anesthesia with Muscle Paralysis and Mechanical Ventilation. J Am Soc Anesthesiol 62:247–254
Westbrook PR, Stubbs SE, Sessler AD, Rehder K, Hyatt RE (1973) Effects of anesthesia and muscle paralysis on respiratory mechanics in normal man. J Appl Physiol 34:81–86
Sigurdsson S, Svantesson C, Larsson A, Jonson B (2000) Elastic pressure–volume curves indicate derecruitment after a single deep expiration in anaesthetised and muscle-relaxed healthy man. Acta Anaesthesiol Scand 44:980–984
Slutsky AS (2010) Neuromuscular blocking agents in ARDS. N Engl J Med 363:1176–1180
Fanelli V, Morita Y, Cappello P, Ghazarian M, Sugumar B, Delsedime L et al (2016) Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine receptor-α1. J Am Soc Anesthesiol 124:132–140
Marik PE, Kaufman D (1996) THe effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Chest 109:1038–1042
Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J (1999) Spontaneous breathing during ventilatory support improves ventilation–perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 159:1241–1248
Freebairn RC, Derrick J, Gomersall CD, Young RJ, Joynt GM (1997) Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 25:72–77
Hraiech S, Yoshida T, Papazian L (2015) Balancing neuromuscular blockade versus preserved muscle activity: Curr. Opin Crit Care 21:26–33
Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y (2013) The comparison of spontaneous breathing and muscle paralysis in two different severities of experimental lung injury. Crit Care Med 41:536–545
Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care [Internet]. 2015 [cité 28 janv 2016];19. Disponible sur: http://ccforum.com/content/19/1/274
Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F et al (2005) Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33:711–715
Fan E, Dowdy DW, Colantuoni E, Mendez-Tellez PA, Sevransky JE, Shanholtz C et al (2014) Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 42:849–859
Ali NA, O’Brien JM, Hoffmann SP, Phillips G, Garland A, Finley JCW et al (2008) Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 178:261–268
De Jonghe B, Sharshar T, Lefaucheur J et al (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867
De Jonghe B, Bastuji-Garin S, Durand M-C, Malissin I, Rodrigues P, Cerf C et al (2007) Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 35:2007–2015
De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L (2004) Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 30:1117–1121
Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348–1353
Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H et al (2007) Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175:480–489
Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S et al (2013) Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621–629
Griffiths RD, Hall JB (2010) Intensive care unit-acquired weakness. Crit Care Med 38:779–787
Hansen-Flaschen J, Cowen J, Raps EC (1993) Neuromuscular blockade in the intensive care unit: more than we bargained for. Am Rev Respir Dis 147:234–236
Testelmans D, Maes K, Wouters P, Powers SK, Decramer M, Gayan-Ramirez G (2007) Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function. Intensive Care Med 33:872–879
Hardin KA, Seyal M, Stewart T, Bonekat HW (2006) Sleep in critically ill chemically paralyzed patients requiring mechanical ventilation. Chest 129:1468–1477
Ballard N, Robley L, Barrett D, Fraser D, Mendoza I (2006) Patients’ recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 15:86–94
Inoue S, Kawaguchi M, Sasaoka N, Hirai K, Furuya H (2006) Effects of neuromuscular block on systemic and cerebral hemodynamics and bispectral index during moderate or deep sedation in critically ill patients. Intensive Care Med 32:391–397
Schuller PJ, Newell S, Strickland PA, Barry JJ (2015) Response of bispectral index to neuromuscular block in awake volunteers. Br J Anaesth 115:i95–103
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup, Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lehingue, S., Hraiech, S., Papazian, L. (2017). Pharmacological Interventions: Neuromuscular Blocking Agents. In: Chiumello, D. (eds) Acute Respiratory Distress Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-41852-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-41852-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41850-6
Online ISBN: 978-3-319-41852-0
eBook Packages: MedicineMedicine (R0)